Exelixis
EXEL
#1730
Rank
NZ$20.43 B
Marketcap
NZ$76.23
Share price
-0.95%
Change (1 day)
19.98%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company